Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

Teh, T-C; Nguyen, N-Y; Moujalled, D M; Segal, D; Pomilio, G; Rijal, S; Jabbour, A; Cummins, K; Lackovic, K; Blombery, P; Thompson, E; Ekert, P G; Lessene, G; Glaser, S P; Huang, D C S; Roberts, A W; Guthridge, Mark; Wei, A H

File(s) under permanent embargo

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

journal contribution

posted on 2018-01-01, 00:00 authored by T-C Teh, N-Y Nguyen, D M Moujalled, D Segal, G Pomilio, S Rijal, A Jabbour, K Cummins, K Lackovic, P Blombery, E Thompson, P G Ekert, G Lessene, S P Glaser, D C S Huang, A W Roberts, Mark GuthridgeMark Guthridge, A H Wei

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

History

Journal

Leukemia

Volume

32

Issue

2

Pagination

303 - 312

Publisher

Springer

Location

Berlin, Germany

Publisher DOI

https://doi.org/10.1038/leu.2017.243

ISSN

0887-6924

eISSN

1476-5551

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology Hematology ANTI-APOPTOTIC MCL-1 ANTAGONIST ABT-737 BH3-ONLY PROTEINS CELL-DEATH BCL-2 ABT-199 INHIBITION IDARUBICIN PUMA PHARMACOKINETICS

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

History

Journal

Volume

Issue

Pagination

Publisher

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports